Multi-site Left Ventricular (MSLV) Pacing With Quartet 1458Q Lead

Abbott Medical Devices10 sites in 2 countries61 target enrollmentFebruary 2010

Overview

The purpose of this clinical investigation is to evaluate the safety and hemodynamic performance of the MSLV Pacing feature in a clinical setting.

To evaluate the hemodynamic impact of different pacing MSLV configurations.

Registry

clinicaltrials.gov

Start Date

February 2010

End Date

May 2010

Last Updated

7 years ago

Study Type

Observational

Sex

All

Sponsor

Responsible Party

Sponsor

•Patients who have a recognised indication to receive a CRT-D device or an upgrade from a pacemaker or ICD to a CRT-D system.
•Patients have signed an informed consent form indicating their willingness to participate to this study.

•Patients who are unable to comply with the follow-up schedule based on their geographic location or for any reason.
•Patients with second or third degree AV Block
•Patients with intrinsic atrial rhythm \< 40 bpm
•Patients with a previously implanted left ventricular pacing lead.
•Patients who are pregnant.
•Patients currently participating in a clinical investigation that includes an active treatment arm.
•Patients under 18 years of age.
•Patients with a life expectancy of less then 6 months.